Novartis Investigative Site

Santa Fe, New Mexico 87505

0 studies enrolling now · 3 studies all time

What they study most

Ankylosing Spondylitis, Breast Neoplasms, Neoplasms, Breast

Studies at this site

• Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis — Completed
• Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer — Completed
• Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer — Completed